Bordetella Bronchiseptica Infection in Cats: ABCD Guidelines on Prevention and Management
2009
Egberink, Herman | Addie, Diane | Belák, Sándor | Boucraut-Baralon, Corine | Frymus, Tadeusz | Gruffydd-Jones, Tim | Hartmann, Katrin | Hosie, Margaret J | Lloret, Albert | Lutz, Hans | Marsilio, Fulvio | Pennisi, Maria Grazia | Radford, Alan D | Thiry, Etienne | Truyen, Uwe | Horzinek, Marian C.
OverviewBordetella bronchiseptica is a Gram-negative bacterium that colonises the respiratory tract of mammals and is considered to be a primary pathogen of domestic cats. It is sensible to consider B bronchiseptica as a rare cause of zoonotic infections. The bacterium is susceptible to common disinfectants. Infection The bacterium is shed in oral and nasal secretions of infected cats. Dogs with respiratory disease are an infection risk for cats. The microorganism colonises the ciliated epithelium of the respiratory tract of the host, establishing chronic infections. Disease signs A wide range of respiratory signs has been associated with B bronchiseptica infection, from a mild illness with fever, coughing, sneezing, ocular discharge and lymphadenopathy to severe pneumonia with dyspnoea, cyanosis and death. Diagnosis Bacterial culture and PCR lack sensitivity. Samples for isolation can be obtained from the oropharynx (swabs) or via transtracheal wash/bronchoalveolar lavage. Disease management Antibacterial therapy is indicated, even if the signs are mild. Where sensitivity data are unavailable, tetracyclines are recommended. Doxycycline is the antimicrobial of choice. Cats with severe B bronchiseptica infection require supportive therapy and intensive nursing care.
显示更多 [+] 显示较少 [-]